Fresenius Medical Care AG
FMS
$23.92
$0.100.42%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 807.38M | 720.31M | 665.95M | 583.85M | 714.85M |
| Total Depreciation and Amortization | 1.59B | 1.58B | 1.59B | 1.60B | 1.62B |
| Total Amortization of Deferred Charges | 56.17M | 56.17M | 56.17M | 56.17M | 60.81M |
| Total Other Non-Cash Items | 97.16M | -74.41M | -227.89M | -145.56M | -304.50M |
| Change in Net Operating Assets | 249.73M | 733.70M | 536.07M | 484.40M | 384.45M |
| Cash from Operations | 2.80B | 3.02B | 2.62B | 2.58B | 2.47B |
| Capital Expenditure | -809.89M | -766.95M | -763.33M | -755.30M | -768.17M |
| Sale of Property, Plant, and Equipment | 21.04M | 16.06M | 13.91M | 15.04M | 19.23M |
| Cash Acquisitions | -1.25M | -11.55M | -8.19M | -665.90K | -890.10K |
| Divestitures | 325.10M | 158.45M | 653.71M | 676.89M | 698.65M |
| Other Investing Activities | -324.60K | -39.98M | -31.67M | -31.86M | -21.54M |
| Cash from Investing | -465.32M | -643.97M | -135.58M | -95.89M | -72.72M |
| Total Debt Issued | 1.20B | 1.14B | -44.56M | 146.33M | 117.31M |
| Total Debt Repaid | -2.18B | -1.90B | -1.72B | -2.07B | -1.89B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -151.12M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -479.52M | -479.52M | -375.82M | -375.82M | -375.82M |
| Other Financing Activities | -612.33M | -320.22M | -299.85M | -291.89M | -230.24M |
| Cash from Financing | -2.41B | -1.61B | -2.60B | -2.77B | -2.54B |
| Foreign Exchange rate Adjustments | -68.61M | -63.24M | 8.64M | 27.34M | -52.69M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -141.79M | 703.27M | -110.96M | -254.10M | -197.30M |